Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
23.3%
% of FBT's 31 holdings also in IBRN
16.7%
% of IBRN's 60 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
INTRA-CELLULAR THERAPIES INC | 4.8% | 4.2% | 4.2% |
 |
ALKERMES PLC | 4.1% | 4.1% | 4.1% |
|
ACADIA PHARMACEUTICALS INC | 3.4% | 4.1% | 3.4% |
|
BIOGEN IDEC INC | 3.2% | 3.9% | 3.2% |
 |
ARGENX SE ADR | 3.1% | 4.2% | 3.1% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to IBRN
|
BEIGENE LTD. SPONSORED ADR | 5.2% |
|
GILEAD SCIENCES INC | 4.3% |
|
HALOZYME THERAPEUTICS INC | 4.2% |
|
VERTEX PHARMACEUTICALS INC | 4.2% |
|
AMGEN INC | 4.1% |
|
ALNYLAM PHARMACEUTICALS INC | 3.9% |
|
CORCEPT THERAPEUTICS INC | 3.8% |
|
BIOMARIN PHARMACEUTICAL INC | 3.7% |
|
EXELIXIS INC | 3.5% |
 |
METTLER-TOLEDO INTERNATIONAL | 3.4% |
FBT Underweight Relative to IBRN
|
CATALYST PHARMACEUTICAL PART | -4.7% |
|
PTC THERAPEUTICS INC | -4.4% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.9% |
|
SCHOLAR ROCK HOLDING CORP. | -3.9% |
|
DENALI THERAPEUTICS INC. | -3.7% |
|
SUPERNUS PHARMACEUTICALS INC | -3.7% |
|
EDGEWISE THERAPEUTICS, INC. | -3.3% |
|
INTEGRA LIFESCIENCES HOLDING | -3.1% |
|
DYNE THERAPEUTICS INC | -2.1% |
|
AXOGEN, INC. | -1.6% |